RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R21082264 | G-1 | G-1 is a non-steroidal, high affinity and selective GPR30 agonist with a Ki valu |
| R21082265 | C-82 | C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-c |
| R21082266 | PF-9363；CTX-3648 | |
| R21082267 | MMAF-OMe | Mmaf-ome is a part of ADC and can inhibit mDAMB435/5T4, MDAMB361DYT2, MDAMB468 a |
| R21082268 | Bardoxolone | Bardoxolone is a novel nuclear regulator (NRF-2) activator. |
| R21082269 | BMS777607 | BMS 777607 (BMS 817378) is a met-related inhibitor that inhibits c-Met, Axl, Ron |
| R21082270 | Brivanib alaninate（BMS-582664） | Brivanib Alaninate is the alaninate salt of a vascular endothelial growth factor |
| R21082271 | vx-702 | VX-702 is a P38 MAPK inhibitor , IL-6, IL-1β and TNFα (IC50 = 59, 122 and 99 ng/ |
| R21082272 | PKI-402 | Pki-402 is a potent PI3K and mTOR inhibitor, inhibiting PI3Kα, mTOR, PI3Kβ, PI3K |
| R21082273 | GSK1292263 hydrochloride | Gsk-1292263 is a potent, orally active GPR119 agonist with pEC50 of 6.9 and 6.7 |
| R21082274 | LY573636 | Tasisulam Sodium (LY 573636 Sodium) is a small molecule antitumor agent that inh |
| R21082275 | AT101 | AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL an |
| R21082276 | PF-562771 | AP23848 is a potent Bcr-Abl inhibitor. In a murine model, AP23848 inhibited acti |
| R21082277 | HQL-79 | HQL-79 is a selective and orally active human hematopoietic prostaglandin D synt |
| R21082278 | Nedocromil | Nedocromil inhibits the action or formation of multiple mediators. Which includi |
| R21082279 | THIACETAZONE | Thioacetazone is a thiosemicarbazone that thioacetazone treatment of pulmonary t |
| R21082280 | R547 | R547 is a potent ATP-competitive inhibitor of CDK1/2/4 with Ki of 2 nM/3 nM/1 nM |
| R21082281 | YS-49 | YS-49 is an activator of PI3K/Akt (a downstream target of RhoA). |
| R21082282 | YM-90K hydrochloride | YM90K hydrochloride is an antagonist of AMPA receptor. |
| R21082283 | AG-490 | (E/Z)-AG490 ((E/Z)-Tyrphostin AG490) is a racemate of (E) -Ag490 and (Z) -Ag490. |
| R21082284 | D-6413 | D-64131 is a tubulin polymerization inhibitor that competitively binds to αβ -tu |
| R21082285 | KU14R | KU14R is an insulin receptor antagonist, which can selectively block insulin sec |
| R21082286 | Amsilarotene;TAC-101 | Amsilarotene inhibits the phosphorylation of retinoblastoma gene product (RB) an |
| R21082287 | GW7647 | |
| R21082288 | LY2623091 | LY2623091 (LY-2623091) is an oral halocorticoid receptor antagonist for the trea |
